Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2015

01-11-2015 | Original Article

Glomerular filtration rate-based cystatin C compared to microalbuminuria to detect early stage of diabetic nephropathy in children with type 1 diabetes mellitus

Authors: Farzaneh Rohani, Nakysa Hooman, Sedigheh Moradi, Mehdi Mobarra, Mehri Najafizadeh

Published in: International Journal of Diabetes in Developing Countries | Special Issue 3/2015

Login to get access

Abstract

Microalbuminuria is a sensitive marker to detect early nephropathy in diabetes mellitus. Cystatin C correlates better than serum creatinine with microalbuminuria in type 1 diabetes mellitus (T1D). We evaluated the correlation between microalbuminuria, serum cystatin C (Cyc-C), and serum creatinine (SCr) in diabetic children. A hundred patients with stable T1D and 66 sex-matched healthy children were entered in the study between September 2008 and February 2011. Fasting blood sample was drawn for HbA1C, creatinine, and cystatin C. A. 24-h urine aliquot was collected to measure microalbumin, creatinine, and volume. Glomerular filtration rate estimated based on creatinine (eGFRcr), cystatin C (eGFRCyst C), and creatinine + cystatin C (eGFRCyst C + Cr). Binary logistic regression analysis, chi-square, ANOVA, Student’s t test, and nonparametric median tests were used to analyze data. P < 0.05 was considered significant. Medians serum creatinine and cystatin C of T1D group were significantly different from controls (P < 0.05). Overall, medians eGFRCyst C were higher than eGFRcr, or eGFRCyst C + Cr. Thirty-six children with T1D had microalbuminuria. There was a correlation between microalbuminuria and eGFRCyst C (<60 and >130 ml/min/1.73 m2) (P < 0.05). Medians eGFRcr were significantly lower than medians eGFRCyst C in T1D, regardless of microalbuminuria (P < 0.05). Chronic kidney disease classification according to eGFRcr and eGFRCyst C were not matched (P < 0.05). GFR in healthy children was overestimated by eGFRCyst C and underestimated by eGFRcr. There was higher correlation between abnormal eGFRCyst C and microalbuminuria in diabetic children. eGFRCr detected higher rate of GFR less than 60 ml/min/1.73 m2.
Literature
2.
go back to reference Shakiba M, Afkhami Ardekani M, Orafa AM. A study of the prevalence of micro and macro albuminuria in diabetic patients referring to the diabetic centre in Yazd. J Shahid Sadoughi Univ Med Sci Health Serv. 2003;10:20–4. Shakiba M, Afkhami Ardekani M, Orafa AM. A study of the prevalence of micro and macro albuminuria in diabetic patients referring to the diabetic centre in Yazd. J Shahid Sadoughi Univ Med Sci Health Serv. 2003;10:20–4.
3.
go back to reference Ledson T, Howse MLP, Roberts NB, Kemp GJ, William PS. Cystatin C as a surrogate for glomerular filtration rate in the presence of proteinuria. NDT Plus. 2008;1:194–5.PubMedPubMedCentral Ledson T, Howse MLP, Roberts NB, Kemp GJ, William PS. Cystatin C as a surrogate for glomerular filtration rate in the presence of proteinuria. NDT Plus. 2008;1:194–5.PubMedPubMedCentral
4.
go back to reference Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–6.PubMedCrossRef Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–6.PubMedCrossRef
5.
go back to reference Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysis. Clin Biochem. 2007;40:383–91.PubMedCrossRef Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysis. Clin Biochem. 2007;40:383–91.PubMedCrossRef
6.
go back to reference Bökenkamp A, Laarman CA, Braam KI, van Wijk JA, Kors WA, Kool M, et al. Effect of corticosteroid therapy on low-molecular weight protein markers of kidney function. Clin Chem. 2007;53:2219–21.PubMedCrossRef Bökenkamp A, Laarman CA, Braam KI, van Wijk JA, Kors WA, Kool M, et al. Effect of corticosteroid therapy on low-molecular weight protein markers of kidney function. Clin Chem. 2007;53:2219–21.PubMedCrossRef
7.
go back to reference Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta. 2000;300:83–95.PubMedCrossRef Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta. 2000;300:83–95.PubMedCrossRef
8.
go back to reference Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest. 2005;28:346–9.PubMedCrossRef Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest. 2005;28:346–9.PubMedCrossRef
9.
go back to reference Holmquist P, Torffvit O, Sjöblad S. Metabolic status in diabetes mellitus affects markers for glomerular filtration rate. Pediatr Nephrol. 2003;18:536–40.PubMed Holmquist P, Torffvit O, Sjöblad S. Metabolic status in diabetes mellitus affects markers for glomerular filtration rate. Pediatr Nephrol. 2003;18:536–40.PubMed
10.
go back to reference Karagiannis A, Mikhailidis DP, Tziomalos K, Kakafika AI, Athyros VG. Has the time come for a new definition of microalbuminuria? Curr Vasc Pharmacol. 2008;6:81–3.PubMedCrossRef Karagiannis A, Mikhailidis DP, Tziomalos K, Kakafika AI, Athyros VG. Has the time come for a new definition of microalbuminuria? Curr Vasc Pharmacol. 2008;6:81–3.PubMedCrossRef
11.
go back to reference Toto RD. Microalbuminuria: definition, detection, and clinical significance. J Clin Hypertens (Greenwich). 2004;6 Suppl 3:2–7.CrossRef Toto RD. Microalbuminuria: definition, detection, and clinical significance. J Clin Hypertens (Greenwich). 2004;6 Suppl 3:2–7.CrossRef
12.
go back to reference Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S, et al. Derivation and validation of cystatin c-based prediction equations for GFR in children. Am J Kidney Dis. 2006;48:221–30.PubMedCrossRef Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S, et al. Derivation and validation of cystatin c-based prediction equations for GFR in children. Am J Kidney Dis. 2006;48:221–30.PubMedCrossRef
13.
go back to reference Oddoze C, Morange S, Portugal H, Berland Y, Dussol B. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis. 2001;38:310–6.PubMedCrossRef Oddoze C, Morange S, Portugal H, Berland Y, Dussol B. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis. 2001;38:310–6.PubMedCrossRef
14.
go back to reference Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem. 2007;53:480–8.PubMedCrossRef Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem. 2007;53:480–8.PubMedCrossRef
15.
go back to reference Zhang PP, Zhan JF, Xie HL, Li LS, Liu ZH. Evaluation of glomerular filtration rate using cystatin c in diabetic patients analysed by multiple factors including tubular function. J Int Med Res. 2010;38:473–48.PubMedCrossRef Zhang PP, Zhan JF, Xie HL, Li LS, Liu ZH. Evaluation of glomerular filtration rate using cystatin c in diabetic patients analysed by multiple factors including tubular function. J Int Med Res. 2010;38:473–48.PubMedCrossRef
16.
go back to reference Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin c, and urine albumin to creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305:1545–52.PubMedPubMedCentralCrossRef Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin c, and urine albumin to creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305:1545–52.PubMedPubMedCentralCrossRef
18.
go back to reference Van Deventer HE, Paiker JE, Katz IJ, George JA. A comparison of cystatin c and creatinine bases prediction equations for the estimation of glomerular filtration rate in black South Africans. Nephrol Dial Transplant. 2011;26:1553–8.PubMedPubMedCentralCrossRef Van Deventer HE, Paiker JE, Katz IJ, George JA. A comparison of cystatin c and creatinine bases prediction equations for the estimation of glomerular filtration rate in black South Africans. Nephrol Dial Transplant. 2011;26:1553–8.PubMedPubMedCentralCrossRef
19.
go back to reference Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, et al. Serum concentrations of markers of TNF-alpha and FAS-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2009;4:62–70.PubMedPubMedCentralCrossRef Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, et al. Serum concentrations of markers of TNF-alpha and FAS-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2009;4:62–70.PubMedPubMedCentralCrossRef
21.
go back to reference Ficociello LH, Perkins BA, Roshan B, Weinberg JM, Aschengrau A, Warram JH, et al. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care. 2009;32:889–93.PubMedPubMedCentralCrossRef Ficociello LH, Perkins BA, Roshan B, Weinberg JM, Aschengrau A, Warram JH, et al. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care. 2009;32:889–93.PubMedPubMedCentralCrossRef
22.
go back to reference Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ. The clinical significance of hyperfiltration in diabetes. Diabetologia. 2010;53:2093–104.PubMedCrossRef Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ. The clinical significance of hyperfiltration in diabetes. Diabetologia. 2010;53:2093–104.PubMedCrossRef
23.
go back to reference Stevens LA, Schmid CH, Zhang YL, Coresh J, Manzi J, Landis R, et al. Levey AS development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant. 2010;25:449–57.PubMedPubMedCentralCrossRef Stevens LA, Schmid CH, Zhang YL, Coresh J, Manzi J, Landis R, et al. Levey AS development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant. 2010;25:449–57.PubMedPubMedCentralCrossRef
24.
go back to reference Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH. Diabetic nephropathy. Diabetol Metabc Syndr. 2009;1:10.CrossRef Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH. Diabetic nephropathy. Diabetol Metabc Syndr. 2009;1:10.CrossRef
25.
go back to reference Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 2007;18:1353–61.PubMedCrossRef Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 2007;18:1353–61.PubMedCrossRef
26.
go back to reference Mojiminiyi OA, Abdella N. Evaluation of cystatin C and beta-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus. J Diabetes Complications. 2003;17:160–8.PubMedCrossRef Mojiminiyi OA, Abdella N. Evaluation of cystatin C and beta-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus. J Diabetes Complications. 2003;17:160–8.PubMedCrossRef
28.
go back to reference Rohani F, Hooman N, Moradi S, Mobarra M, Najafizadeh M, Tatarpoor P. The prevalence of pre-hypertension in children with type 1 diabetes mellitus. Int J Prev Med. 2014;5 Suppl 1:S44–9.PubMedPubMedCentral Rohani F, Hooman N, Moradi S, Mobarra M, Najafizadeh M, Tatarpoor P. The prevalence of pre-hypertension in children with type 1 diabetes mellitus. Int J Prev Med. 2014;5 Suppl 1:S44–9.PubMedPubMedCentral
29.
go back to reference Hooman N, Roohani F, Moradi S, Mobarra M, Najafizadeh M. Cystatin C as an early marker of diabetic nephropathy in children with type 1 diabetes mellitus. Pediatr Nephrol. 2013;28:1533–689.CrossRef Hooman N, Roohani F, Moradi S, Mobarra M, Najafizadeh M. Cystatin C as an early marker of diabetic nephropathy in children with type 1 diabetes mellitus. Pediatr Nephrol. 2013;28:1533–689.CrossRef
Metadata
Title
Glomerular filtration rate-based cystatin C compared to microalbuminuria to detect early stage of diabetic nephropathy in children with type 1 diabetes mellitus
Authors
Farzaneh Rohani
Nakysa Hooman
Sedigheh Moradi
Mehdi Mobarra
Mehri Najafizadeh
Publication date
01-11-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue Special Issue 3/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0297-0

Other articles of this Special Issue 3/2015

International Journal of Diabetes in Developing Countries 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.